Related references
Note: Only part of the references are listed.An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
F. Crea et al.
ANNALS OF ONCOLOGY (2012)
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
Yotaro Kudo et al.
CANCER SCIENCE (2012)
The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia
David A. Ahlquist et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Review of biomarkers in colorectal cancer
K. F. Newton et al.
COLORECTAL DISEASE (2012)
TCF12 Protein Functions as Transcriptional Repressor of E-cadherin, and Its Overexpression Is Correlated with Metastasis of Colorectal Cancer
Chun-Chung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Detection of Hypermethylated Vimentin in Urine of Patients with Colorectal Cancer
Benjamin P. Song et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer
Matthias P. A. Ebert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
Byung-Hoon Min et al.
BMC CANCER (2011)
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Jorja D. Warren et al.
BMC MEDICINE (2011)
DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer
Joong Bae Ahn et al.
CANCER (2011)
Clinical Implications of UGT1A1*28 Genotype Testing in Colorectal Cancer Patients
Katerina Shulman et al.
CANCER (2011)
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers
Kaori Shima et al.
CANCER CAUSES & CONTROL (2011)
MicroRNA Signatures: Novel Biomarker for Colorectal Cancer?
Xiaoya Luo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Epigenetic Alteration of DNA in Mucosal Wash Fluid Predicts Invasiveness of Colorectal Tumors
Seiko Kamimae et al.
CANCER PREVENTION RESEARCH (2011)
Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer
Kazuyuki Kawakami et al.
CANCER SCIENCE (2011)
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
Masashi Takawa et al.
CANCER SCIENCE (2011)
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients
James B. Rawson et al.
CARCINOGENESIS (2011)
Colorectal Cancers with Microsatellite Instability Display Unique miRNA Profiles
Francesc Balaguer et al.
CLINICAL CANCER RESEARCH (2011)
Moving Closer to a Prognostic DNA Methylation Signature in Colon Cancer
F. Javier Carmona et al.
CLINICAL CANCER RESEARCH (2011)
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea et al.
DRUG RESISTANCE UPDATES (2011)
MicroRNA-21 and PDCD4 expression in colorectal cancer
K. H. Chang et al.
EJSO (2011)
5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
Rodrigo Jover et al.
GASTROENTEROLOGY (2011)
Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta-analysis
Y. -X. Luo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Colorectal Cancer Epigenetics: Complex Simplicity
Manon van Engeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
Guro E. Lind et al.
MOLECULAR CANCER (2011)
Epigenetics and colorectal cancer
Victoria Valinluck Lao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Screening for colorectal cancer: established and emerging modalities
Nikhil Pawa et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
LINE-1 Hypomethylation During Primary Colon Cancer Progression
Eiji Sunami et al.
PLOS ONE (2011)
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
B. Glimelius et al.
PHARMACOGENOMICS JOURNAL (2011)
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
Markus Vogt et al.
VIRCHOWS ARCHIV (2011)
Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
Diana Connolly et al.
BREAST CANCER RESEARCH (2011)
Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells
Anne-Sophie Belanger et al.
BMC MOLECULAR BIOLOGY (2010)
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Alexander Link et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer
Qiong He et al.
CANCER GENETICS AND CYTOGENETICS (2010)
MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening
Yoshikatsu Koga et al.
CANCER PREVENTION RESEARCH (2010)
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Zhaohui Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Clinical Relevance of Microsatellite Instability in Colorectal Cancer
Albert de la Chapelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors
Yoshifumi Baba et al.
MOLECULAR CANCER (2010)
Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer
Hajime Shibuya et al.
ONCOLOGY (2010)
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome
Massimo Pancione et al.
PLOS ONE (2010)
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
Nicola Valeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis
Cheng-Gang Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status
Eri Arai et al.
EPIGENOMICS (2010)
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
O. Fluge et al.
BRITISH JOURNAL OF CANCER (2009)
Promoter Methylation of the Wnt/beta-Catenin Signaling Antagonist Dkk-3 Is Associated With Poor Survival in Gastric Cancer
Jun Yu et al.
CANCER (2009)
Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2009)
Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer
Bo Bin Lee et al.
CLINICAL CANCER RESEARCH (2009)
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Theo deVos et al.
CLINICAL CHEMISTRY (2009)
Stool Methylation-Specific Polymerase Chain Reaction Assay for the Detection of Colorectal Neoplasia in Korean Patients
Yoo Hum Baek et al.
DISEASES OF THE COLON & RECTUM (2009)
Germline Hypermethylation of MLH1 and EPCAM Deletions Are a Frequent Cause of Lynch Syndrome
Renee C. Niessen et al.
GENES CHROMOSOMES & CANCER (2009)
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
E. K. O. Ng et al.
GUT (2009)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection
Steven Itzkowitz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response
S. Cheetham et al.
BRITISH JOURNAL OF CANCER (2008)
Diagnostic and prognostic microRNAs in stage II colon cancer
Troels Schepeler et al.
CANCER RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer:: Specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert et al.
CLINICAL CANCER RESEARCH (2008)
Combination of O6-methylguanine-DNA methyltransferase and thymidylate synthase for the prediction of fluoropyrimidine efficacy
Takako Eguchi Nakajima et al.
EUROPEAN JOURNAL OF CANCER (2008)
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
A. Walther et al.
GUT (2008)
Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis
Takeshi Nagasaka et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
Shuji Ogino et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Robert Gruetzmann et al.
PLOS ONE (2008)
A microRNA DNA methylation signature for human cancer metastasis
Amaia Lujambio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening
Dao-Rong Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
SFRP2 methylation in fecal DNA - a marker for colorectal polyps
Michael Oberwalder et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state
Yae Kanai et al.
CARCINOGENESIS (2007)
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil - Based chemotherapy
Lanlan Shen et al.
CLINICAL CANCER RESEARCH (2007)
DNA stool test for colorectal cancer:: Hypermethylation of the secreted frizzled-related protein-1 gene
Wei Zhang et al.
DISEASES OF THE COLON & RECTUM (2007)
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
Giovanni Lanza et al.
MOLECULAR CANCER (2007)
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers
Eungi Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma
Shuji Ogino et al.
VIRCHOWS ARCHIV (2007)
Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions
Zhao-Hui Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Highly methylated genes in colorectal neoplasia: Implications for screening
Hongzhi Zou et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor
Jian Qi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Tsun Leung Chan et al.
NATURE GENETICS (2006)
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene
WD Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
IT Tai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Methylation changes in faecal DNA:: a marker for colorectal cancer screening?
HM Müller et al.
LANCET (2004)
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
H Suzuki et al.
NATURE GENETICS (2004)
Germline epimutation of MLH1 in individuals with multiple cancers
CM Suter et al.
NATURE GENETICS (2004)
Share Paper
